Jhs Svendgaard Laboratories Limited (JHS)

Loading page…

Jhs Svendgaard Laboratories Limited (JHS) · mywealthgrid

About

Jhs Svendgaard Laboratories Limited operates in Personal Care within the Consumer Staples sector.

Face value: ₹10

Market cap

₹102 Cr

P/E

—

P/B

0.6×

Dividend yield

ROE

-1.1%

ROCE

-0.8%

Debt / equity

0.08

OPM

2.6%

EPS (TTM)

₹-0.2

Book value

₹20.0

52-week high

—

52-week low

—

2,528 historical price candles were omitted because the exchange source has not been verified.

₹11.8+13.8%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0.1)

Cons

−Low return on equity of -5% (3-yr avg)
−Thin operating margin of 2.6%
−Modest revenue growth of 0.2% a year over the last 5 years
−Weak interest coverage of -1.7×

Research score

Structured signal from quality, growth, valuation and momentum.

37/100

Business quality: 19
Growth: 43
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	143	143	139	101	86	96	71	92	102
COGS	90	90	100	68	61	66	44	61	65
Gross profit	53	53	39	32	26	30	27	31	36
	39	39	38	31	27	39	28	35	34
	14	14	2	2	-1	-9	-1	-4	3
OPM %	9.6%	9.6%	1.2%	1.9%	-1%	-9.5%	-1.3%	-4.4%	2.6%
Depreciation	7	7	9	7	7	7	6	8	8
Interest	1	1	2	1	1	1	0	1	1
	32	32	3	8	9	-4	4	0	3
Profit before tax	38	38	-6	2	0	-22	-3	-13	-2
Tax	12	12	-1	1	4	-5	1	7	-0
Tax %	32.2%	32.2%	-12.9%	41.2%	4,390%	-23.2%	18.4%	57.5%	-16.2%
	26	26	-5	1	-4	-17	-4	-20	-2
PAT margin %	18.3%	18.3%	-3.5%	1.3%	-5%	-17.4%	-5.7%	-21.4%	-1.9%
EPS (₹)	4.6	4.6	-0.3	0.2	-0.6	-1.5	-0.5	-2.4	-0.2
EPS adjusted (₹)	7	5.9	—	0.2	-0.5	-2.4	-0.5	-2.3	-0.2
Annual report	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2017	Mar 2018	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	38	44	64	78	65	78	86	87
Reserves	63	91	124	—	108	91	87	87
Minority interest	—	0	9	—	8	—	0	—
	2	1	0	—	0	4	5	15
	19	20	30	—	56	24	23	26
Total equity & liabilities	121	156	228	—	236	197	201	215
	65	65	59	56	66	89	90	89
CWIP	1	1	9	—	9	1	0	4
Investments	1	18	6	—	1	3	4	5
	55	72	154	—	160	104	107	117
Total assets	121	156	228	—	236	197	201	215

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2023 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Manufacturing Business	81.92	-15.14	—	11.73
Retail Business	11.39	0.75	—	-1.43
Other than Manufacturing	3.99	-2.3

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	36.9%	28.4%	32.2%	29.9%	31.5%	37.6%	33.7%	35.9%
EBITDA margin %	9.6%	1.2%	1.9%	-1%	-9.5%	-1.3%	-4.4%	2.6%
EBIT margin %	4.9%	-5.1%	-5.3%	-9.2%	-17.2%	-10.3%	-13%	-4.8%
PAT margin %	18.3%	-3.5%	1.3%	-5%	-17.4%	-5.7%	-21.4%	-1.9%
Working capital
Receivable days	35	—	213	—	78	66	52	60
Inventory days	43	—	62	—	76	105	71	85
Payable days	—	—	85	—	118	117	80	100
NWC days	—	—	189	—	36	54	42	45
Leverage
Current ratio	2.06	—	5.23	—	2.36	1.87	2.18	1.94
Debt to EBITDA	0.05	—	0.24	—	—	—	—	5.65
Debt to equity	0	—	0	—	0	0.02	0.03	0.08
Interest coverage	16.1	3.5	1.8	1.1	-2.1	-6.5	-16.2	-1.7
Asset turnover	0.92	—	0.44	—	0.41	0.36	0.46	0.47
Return ratios
Return on assets %	16.7%	—	0.6%	—	-7.1%	-2.1%	-9.8%	-0.9%
Return on capital employed %	10%	—	1.1%	—	-1.1%	-1.6%	-5.2%	-0.8%
Return on equity %	19.3%	—	0.7%	—	-9.7%	-2.4%	-11.4%	-1.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	37.73%	37.73%	37.73%	37.73%	34.56%	34.56%	34.56%	34.56%	34.56%	34.56%	33.85%	33.85%
	0%	0%	2.3%	0.15%	1.69%	1.59%	1.6%	1.59%	1.57%	1.57%	3.6%	3.14%
DII	0%	9.16%	6.21%	6.05%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	62.27%	53.11%	53.76%	56.07%	63.75%	63.85%	63.84%	63.85%	63.87%	63.87%	62.55%	63.01%
No. of shareholders	—	—	—	—	—	—	—	—	25,007	25,151	25,330	25,150

Promoter holding down 3.88 percentage points since Sep 2023.

19 deals · 10 Aug 2021 – 4 Sept 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
4 Sept 2025	NIMISHA KHANDU SOLANKI	Bulk	NSE	Buy	5,93,100	₹12.00	₹0.71 Cr
4 Sept 2025	GREEN PORTFOLIO PRIVATE LIMITED	Bulk	NSE	Sell	5,37,363	₹11.62	₹0.62 Cr
4 Sept 2024	ASPIRE EMERGING FUND	Bulk	NSE	Sell	15,00,000	₹28.13	₹4.22 Cr
4 Sept 2024	AEGIS INVESTMENT FUND	Bulk	NSE	Buy	14,31,000	₹28.13	₹4.03 Cr
23 Aug 2024	SIXTH SENSE INDIA OPPORTUNITIES 11	Bulk	NSE	Sell	5,51,400	₹24.93	₹1.37 Cr
8 Aug 2024	SIXTH SENSE INDIA OPPORTUNITIES 11	Bulk	NSE	Sell	5,00,000	₹24.44	₹1.22 Cr
7 Aug 2024	SIXTH SENSE INDIA OPPORTUNITIES 11	Bulk	NSE	Sell	11,40,000	₹22.22	₹2.53 Cr
31 Jul 2024	SIXTH SENSE INDIA OPPORTUNITIES 11	Bulk	NSE	Sell	10,19,000	₹23.03	₹2.35 Cr
31 Jul 2024	MANOJ DUA	Bulk	NSE	Buy	6,57,008	₹23.03	₹1.51 Cr
29 Jul 2024	ZAVERI FINSTOCK PVT. LTD.	Bulk	NSE	Sell	4,68,213	₹22.13	₹1.04 Cr

1–10 of 19

1 / 2

Mr. RAJAGOPAL CHAKRAVARTHI VENKATEISHNon-Executive - Independent Director-Chairperson
Mr. NIKHIL NANDAExecutive Director-MD
Paramvir SinghChief Executive Officer
Mr. KAPIL MINOCHANon-Executive - Independent Director
Mr. Ashish GoelChief Financial Officer
Mr. VINAY MITTALNon-Executive - Non Independent Director
Mrs. UPMA CHAWDHRYNon-Executive - Independent Director
Mr. PARAMVIR SINGHExecutive Director-CEO
Mr. Neeraj KumarJoint Chief Financial Officer
Mrs. Komal JhaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Jhs Svendgaard Laboratories Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

3

Final dividend26 Dec 2011 · ex-date₹0.75
Final dividend22 Dec 2010 · ex-date₹0.5
Dividend dividend10 Sept 2009 · ex-date₹0.25

1

Board meeting to consider results11 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

72 announcementsExport CSV

29 Sept 2026, 4:19 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

Loading announcements…

Ratio	Mar 2018	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	36.9%	28.4%	32.2%	29.9%	31.5%	37.6%	33.7%	35.9%
EBITDA margin %	9.6%	1.2%	1.9%	-1%	-9.5%	-1.3%	-4.4%	2.6%
EBIT margin %	4.9%	-5.1%	-5.3%	-9.2%	-17.2%	-10.3%	-13%	-4.8%
PAT margin %	18.3%	-3.5%	1.3%	-5%	-17.4%	-5.7%	-21.4%	-1.9%
Working capital
Receivable days	35	—	213	—	78	66	52	60
Inventory days	43	—	62	—	76	105	71	85
Payable days	—	—	85	—	118	117	80	100
NWC days	—	—	189	—	36	54	42	45
Leverage
Current ratio	2.06	—	5.23	—	2.36	1.87	2.18	1.94
Debt to EBITDA	0.05	—	0.24	—	—	—	—	5.65
Debt to equity	0	—	0	—	0	0.02	0.03	0.08
Interest coverage	16.1	3.5	1.8	1.1	-2.1	-6.5	-16.2	-1.7
Asset turnover	0.92	—	0.44	—	0.41	0.36	0.46	0.47
Return ratios
Return on assets %	16.7%	—	0.6%	—	-7.1%	-2.1%	-9.8%	-0.9%
Return on capital employed %	10%	—	1.1%	—	-1.1%	-1.6%	-5.2%	-0.8%
Return on equity %	19.3%	—	0.7%	—	-9.7%	-2.4%	-11.4%	-1.1%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Godrej Consumer Products LimitedGODREJCPGODREJCP	₹85,949 Cr	₹90,085 Cr	₹16,050 Cr	₹3,257 Cr	20.8%	₹2,052 Cr	12.3%	23.9%	15.1%	12
Colgate Palmolive (India) LimitedCOLPALCOLPAL	₹47,192 Cr	₹47,192 Cr	₹6,204 Cr	₹1,900 Cr	31%	₹1,348 Cr	22%	106.4%	81.6%	-188
Cupid LimitedCUPIDCUPID	₹42,022 Cr	₹42,073 Cr	₹453 Cr	₹160 Cr	32.6%	₹137 Cr	30.3%	35.4%	27.3%	200
Gillette India LimitedGILLETTEGILLETTE	₹22,491 Cr	₹22,491 Cr	₹3,176 Cr	₹961 Cr	30.3%	₹668 Cr	21%	—	—	—
Procter & Gamble Hygiene And Health Care LimitedPGHHPGHH	₹21,577 Cr	₹21,577 Cr	₹4,245 Cr	₹1,075 Cr	25.3%	₹791 Cr	18.6%	—	—	—
Emami LimitedEMAMILTDEMAMILTD	₹16,266 Cr	₹16,389 Cr	₹3,915 Cr	₹976 Cr	25.5%	₹748 Cr	20.5%	30.3%	27.6%	8
Honasa Consumer LimitedHONASAHONASA	₹13,950 Cr	₹13,950 Cr	₹2,553 Cr	₹301 Cr	9.9%	₹249 Cr	8.4%	19.5%	15.4%	-78
Bajaj Consumer Care LimitedBAJAJCONBAJAJCON	₹6,516 Cr	₹6,516 Cr	₹1,240 Cr	₹264 Cr	19%	₹223 Cr	16.3%	30.5%	25.3%	42
Recode Studios LtdRECODERECODE	₹477 Cr	—	₹80 Cr	₹17 Cr	20.7%	₹11 Cr	14%	—	—	—
Radix Industries (India) LtdRADIXINDRADIXIND	₹193 Cr	₹193 Cr	₹48 Cr	₹4 Cr	7.6%	₹3 Cr	6.3%	19.6%	14.5%	65
H. R. Hygiene Products LtdHRHYGIENEHRHYGIENE	₹143 Cr	—	—	—	—	—	—	—	—	—
Jhs Svendgaard Laboratories LimitedJHSJHS	₹102 Cr	₹117 Cr	₹109 Cr	₹3 Cr	2.6%	₹-2 Cr	-1.9%	-0.8%	-1.1%	45

Date	Category	Subject	Filing
29 Sept 2026, 4:19 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
21 Sept 2026, 6:02 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
17 Sept 2026, 11:11 am	Company Update General	Letter To Shareholders	PDF
3 Sept 2026, 5:08 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
2 Sept 2026, 4:20 pm	AGM/EGM AGM	Notice Of 22Nd Annual General Meeting	PDF
2 Sept 2026, 4:14 pm	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF
29 Aug 2026, 4:25 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
11 Aug 2026, 5:00 pm	Company Update Reg. 32 (1), (3) - Statement of Deviation & Variation	Statement Of Deviation & Variation	PDF

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-4	13	-11	10	12	-9	19	-9	-5	-3
	-3	-0	-7	-11	-2	-5	10	-21	-20	-12
	10	-13	13	0	10	-2	10	2	23	11
Net cash flow	3	0	-5	-0	20	-16	39	-28	-2	-3
Free cash flow	-17	—	-26	0	4	-16	18	-33	-15	-15
CFO / Operating profit %	-28.6%	95.8%	—	623.5%	626.6%	—	—	—	—	-101.5%

Jhs Svendgaard Laboratories Limited

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

3

1

Announcements

3

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Segment results

Compounded sales growth

Return on equity

Manufacturing Business · revenue

Jhs Svendgaard Laboratories Limited

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Dividends3

Board meetings1

Announcements

Dividends3

Board meetings1

Ratio timeline

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Return on equity

Manufacturing Business · revenue

3

1

3

1